--- title: "Option Care Health | 8-K: FY2026 Q2 Revenue Beats Estimate at USD 1.442 B" type: "News" locale: "en" url: "https://longbridge.com/en/news/294195294.md" datetime: "2026-07-29T10:58:38.000Z" locales: - [zh-CN](https://longbridge.com/zh-CN/news/294195294.md) - [en](https://longbridge.com/en/news/294195294.md) - [zh-HK](https://longbridge.com/zh-HK/news/294195294.md) generator: "portal-rs" --- # Option Care Health | 8-K: FY2026 Q2 Revenue Beats Estimate at USD 1.442 B Revenue: As of FY2026 Q2, the actual value is USD 1.442 B, beating the estimate of USD 1.419 B. EPS: As of FY2026 Q2, the actual value is USD 0.35, beating the estimate of USD 0.3326. EBIT: As of FY2026 Q2, the actual value is USD 88.01 M. Option Care Health, Inc. reported key financial metrics for the second quarter and six months ended June 30, 2026. #### Second Quarter 2026 Financial Highlights Net revenue for the second quarter ended June 30, 2026, was $1,442 million, representing a 1.9% increase year-over-year. GAAP net income rose by 6.7% compared to the prior year, reaching $53.9 million. Adjusted EBITDA increased by 3.0% year-over-year to $117.5 million. Cash provided by operating activities during the second quarter was $184 million. The company repurchased $150 million of its outstanding shares in the quarter. #### Six Months Ended June 30, 2026 Financial Performance Net revenue for the six months ended June 30, 2026, was $2,793,054 thousand, up from $2,749,057 thousand in the same period of 2025. Cost of revenue was $2,263,789 thousand, compared to $2,216,962 thousand in 2025. Gross profit slightly decreased to $529,265 thousand from $532,095 thousand in 2025. Operating costs and expenses totaled $371,580 thousand, a slight increase from $370,197 thousand in 2025. This included selling, general and administrative expenses of $331,065 thousand ($330,275 thousand in 2025), restructuring, acquisition, integration and other expenses of $8,156 thousand ($7,935 thousand in 2025), and depreciation and amortization expense of $32,359 thousand ($31,987 thousand in 2025). Operating income for the period was $157,685 thousand, down from $161,898 thousand in 2025. Total other (expense) income was - $22,695 thousand, an improvement from - $29,481 thousand in 2025. This included net interest expense of - $27,324 thousand (- $27,678 thousand in 2025) and other, net income of $4,629 thousand (- $1,803 thousand in 2025). Income before income taxes increased to $134,990 thousand from $132,417 thousand in 2025. Income tax expense was $35,734 thousand, compared to $35,152 thousand in 2025. Net income for the six months was $99,256 thousand, up from $97,265 thousand in 2025. #### Cash Flow Net cash provided by operating activities for the six months ended June 30, 2026, significantly increased to $171,485 thousand from $83,119 thousand in the prior year period. Key changes contributing to this included a - $37,941 thousand change in accounts receivable, net, and a $71,544 thousand change in inventories. Net cash used in investing activities was - $21,000 thousand, primarily due to - $20,123 thousand for the acquisition of property and equipment. This compares to - $135,713 thousand in the prior year, which included - $117,247 thousand for business acquisitions. Net cash used in financing activities amounted to - $189,342 thousand, including - $170,545 thousand for the purchase of company stock and related excise taxes. #### Balance Sheet As of June 30, 2026, total assets were $3,378,777 thousand, a decrease from $3,455,769 thousand at year-end 2025. Cash and cash equivalents decreased to $193,767 thousand from $232,624 thousand at year-end 2025. Inventories were $399,605 thousand, down from $471,149 thousand. Goodwill remained flat at $1,606,743 thousand. Total liabilities decreased to $2,118,879 thousand from $2,129,376 thousand at year-end 2025. Long-term debt, net, was $1,152,040 thousand, slightly down from $1,154,052 thousand. Stockholders’ equity decreased to $1,259,898 thousand from $1,326,393 thousand at year-end 2025. #### Outlook / Guidance For the full year 2026, Option Care Health, Inc. anticipates net revenue between $5.675 billion and $5.775 billion, with Adjusted EBITDA projected to range from $480 million to $495 million. The company expects cash provided by operating activities to be at least $320 million for the full year. For the third quarter of 2026, the company projects sequential net revenue growth in the low to mid single-digits and sequential Adjusted EBITDA growth in the mid single-digits compared to the second quarter of 2026. ### Related Stocks - [OPCH.US](https://longbridge.com/en/quote/OPCH.US.md) ## Related News & Research - [Option Care Health: Hold Rating Reiterated as Risk-Reward Seen Balanced; $23 Price Target Maintained](https://longbridge.com/en/news/294637288.md) - [Option Care Health (OPCH) Reports Earnings Tomorrow: What To Expect](https://longbridge.com/en/news/294004750.md) - [OPKO Health (OPK) Stock Looks Stretched On Fresh Royalty Backed Financing](https://longbridge.com/en/news/296514557.md) - [Charles River and MVC to develop enterovirus vaccine](https://longbridge.com/en/news/296594849.md) - [Vilniaus Baldai appoints Grant Thornton Baltic as auditor for 2026-27 financial statements](https://longbridge.com/en/news/296367543.md) --- > **Disclaimer: This article is for reference only and does not constitute any investment advice.**